SIFROL

This brand name is authorized in Australia, Austria, Brazil, Croatia, Estonia, Finland, France, Germany, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Singapore, Tunisia.

Active ingredients

The drug SIFROL contains one active pharmaceutical ingredient (API):

1	Pramipexole UNII 3D867NP06J - PRAMIPEXOLE DIHYDROCHLORIDE
	Pramipexole is a dopamine agonist that binds with high selectivity and specificity to the D2 subfamily of dopamine receptors of which it has a preferential affinity to D3 receptors, and has full intrinsic activity. Pramipexole alleviates parkinsonian motor deficits by stimulation of dopamine receptors in the striatum. Animal studies have shown that pramipexole inhibits dopamine synthesis, release, and turnover.
	Read more about Pramipexole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SIFROL Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)
SIFROL Tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BC05	Pramipexole	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3418X, 3419Y, 3420B, 3421C, 3422D, 5143Q, 5145T, 9151P, 9152Q, 9153R, 9393J, 9394K
BR	Câmara de Regulação do Mercado de Medicamentos	504503801113217, 504503802111218, 504503803116213, 504503805119317, 504503807111313, 504503809114311, 504503811119315
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00267737, 00268234, 00268240, 00268257, 00434425, 00434431, 00522750, 00578176, 01299811, 01836930, 02460349, 02558692, 03319699, 03319707, 03420748, 03420777, 03864184, 04038100, 04038123, 06439725, 06439748, 07562445, 07562451, 07568086, 07764137, 07764143, 08997872, 08997889, 11080166, 14354339, 14354374, 15637097, 15996703, 16698132, 16698149, 16869177, 16869183, 17545117
EE	Ravimiamet	1204658, 1204669, 1204670, 1204681, 1204692, 1204704, 1204715, 1204726, 1204759, 1204760, 1455870, 1455881, 1455892, 1455904, 1455915, 1455926, 1455937, 1455948, 1455959, 1455960, 1455971, 1455982, 1455993, 1456006, 1456017, 1482588, 1482599, 1482601, 1482612, 1482623, 1482634
FI	Lääkealan turvallisuus- ja kehittämiskeskus	044728, 044739, 044752, 050836, 050847, 062410, 140327, 141432, 515477, 515942
FR	Base de données publique des médicaments	60267171, 66881233, 67432729, 67527910, 69016117, 69922895
IL	מִשְׂרַד הַבְּרִיאוּת	6142, 6143, 6828, 6829, 6830
LT	Valstybinė vaistų kontrolės tarnyba	1030596, 1030597, 1030598, 1030599, 1030600, 1030601, 1030602, 1030603, 1030604, 1030605, 1051350, 1051351, 1051352, 1051353, 1051354, 1051355, 1051356, 1051357, 1051358, 1051359, 1051360, 1051361, 1051362, 1051363, 1051364, 1056016, 1056017, 1056018, 1056019, 1056020, 1056021
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	037M2010, 062M99
NL	Z-Index G-Standaard, PRK	49433, 49468, 91235, 91243, 91251, 91278, 94129
PL	Rejestru Produktów Leczniczych	100316450, 100316467, 100316473, 100316496, 100316504, 100316510, 100316527, 100316533, 100316540, 100316556, 100316562
SG	Health Sciences Authority	11250P, 11253P, 13928P, 13930P
TN	Direction de la Pharmacie et du Médicament	115330210, 115330211, 11533022, 11533023, 11533024, 11533025, 11533026, 11533027, 11533028, 11533029